Study of Treatment High Risk and/or Low Risk Acute Lymphoblastic leuk√©mia(ALL) Adults Stage III
Improved outcome of high risk lymphoblastic leukemia (ALL) with laite high dose therapy.

High dose versus conventional therapy for adult low risk T-ALL and Lymphoblastic lymphoma (LBL).
Leukemia, Lymphocytic, Acute
DRUG: interferon alpha 2a
overall survival, time to death
Efficacy of study treatments, time to end of treatment
Comparison between two autograf therapeutic strategies in high risk patients Ramdomised comparison between maintenance treatment with or not interferon alpha 2 a